No está conectado a la Beloit College red Es posible que tenga que autenticar con su biblioteca para tener acceso a contenido y servicios en linea
Remote Access
Consiguiendo una copia en línea de este material…Encontrar un ejemplar en la biblioteca
Obtener la ubicación y disponibilidad de este material…WorldCat
Encontrarlo en una biblioteca por todo el mundo
Bibliotecas por todo el mundo tienen este material
Detalles
| Género/Forma: | article |
|---|---|
| Tipo de material: | Recurso en Internet |
| Tipo de documento | Recurso internet, Artículo |
| Todos autores / colaboradores: | Trivedi, Mahendra Kumar; Branton, Alice; Trivedi, Dahryn; Nayak, Gopal; Lee, Aileen Carol; Hancharuk, Aksana; Sand, Carola Marina; Schnitzer, Debra Jane; Thanasi, Rudina; Meagher, Eileen Mary; Pyka, Faith Ann; Gerber, Gary Richard; Stromsnas, Johanna Catharina; Shapiro, Judith Marian; Streicher, Laura Nelson; Hachfeld, Lorraine Marie; Hornung, Matthew Charles; Rowe, Patricia M.; Henderson, Sally Jean; Benson, Sheila Maureen; Holmlund, Shirley Theresa; Salters, Stephen P.; Gangwar, Mayank; Jana, Snehasis |
| Nota del idioma: | english |
| Número OCLC: | 1022072004 |
| Notas: | 104 - 113 application/pdf |
Resumen:
The use of herbomineral formulations for different chronic diseases is gaining popularity because these natural formulations have fewer side effects, a higher safety profile, and more cost effectiveness. A new proprietary herbomineral formulation composed of herbs and certain minerals was formulated, consisting of the herbal root extract ashwagandha and the minerals (zinc, magnesium, and selenium). The aim of the study was to evaluate the immunomodulatory potential of a Biofield Energy Healing (The Trivedi Effect®) Treatment on the herbomineral formulation in female Sprague Dawley rats. The test formulation was divided into two parts. One part was denoted as the control without any Biofield Energy Treatment, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment remotely from eighteen renowned Biofield Energy Healers. Immunomodulatory potential, humoral immune response, paw volume, hematological study, biochemistry, body weight, feed intake and histopathology analysis were performed. Humoral immune response data showed increased (p≤0.01) primary antibody titre by 124.7% in the Biofield Treatment test formulation (G3), while the untreated test formulation group (G4) showed decreased antibody titre compared with the disease control group (G2). The secondary antibody titre value in the G3 group was also altered compared with the G2 group. Delayed type hypersensitivity (DTH) data suggest that the Biofield Energy Treated test formulation group (G3) showed a significant decrease in paw volume by 128.57% with respect to the G2 group. Hematology and biochemistry analysis showed altered values, as increased MCHC and RBC count by 138.09% and 7.24%, respectively in the G3 group compared with the G2 and G4 group. However, the platelet count was increased by 17.70% in the G3 group compared with the G2 group. The level of blood urea nitrogen was decreased by 10.90% in the G3 level compared with the G2 group. Ho
Recuperando notas sobre este material